enrofloxacin has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorożyńska, I; Majewska-Szczepanik, M; Marcińska, K; Szczepanik, M | 1 |
| Majewska-Szczepanik, M; Marcińska, K; Strzępa, A; Szczepanik, M | 1 |
2 other study(ies) available for enrofloxacin and transforming growth factor beta
| Article | Year |
|---|---|
Partial depletion of natural gut flora by antibiotic aggravates collagen induced arthritis (CIA) in mice.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Experimental; Enrofloxacin; Fluoroquinolones; Intestines; Male; Mice; Mice, Inbred DBA; Th1 Cells; Th17 Cells; Transforming Growth Factor beta | 2014 |
Oral treatment with enrofloxacin creates anti-inflammatory environment that supports induction of tolerogenic dendritic cells.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Dendritic Cells; Enrofloxacin; Gastrointestinal Microbiome; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-17; Mice; Mice, Inbred C57BL; Peyer's Patches; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2019 |